• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23806 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2011     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Criteria for appropriate use of FDG-PET in breast cancer
2011     NIHR Health Technology Assessment programme Growth monitoring for short stature: update of a systematic review and economic model
2011     Medical Advisory Secretariat (MAS) Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Preoperative skin antiseptic preparations and application techniques for preventing surgical site infections: a systematic review of the clinical evidence and guidelines
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Histamine dihydrochloride (Ceplene®)
2011     NIHR Health Technology Assessment programme Processes in recruitment to randomised controlled trials of medicines for children (RECRUIT): a qualitative study
2011     NIHR Health Technology Assessment programme Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis
2011     Medical Advisory Secretariat (MAS) Diurnal tension curves for assessing the development or progression of glaucoma: an evidence-based analysis
2011     Medical Advisory Secretariat (MAS) Constraint induced movement therapy for rehabilitation of arm dysfunction after stroke in adults
2011     NIHR Horizon Scanning Centre (NIHR HSC) Cetuximab (Erbitux) in combination with oxaliplatin, leucovorin and fluorouracil for colorectal cancer - adjuvant
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sunitinib (Sutent®)
2011     Andalusian Health Technology Assessment Area (AETSA) [Guidelines to produce citizen-friendly health technology assessment reports]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Cetuximab (Erbitux) in combination with capecitabine and cisplatin for advanced or metastatic gastric cancer – first line
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ferric carboxymaltose (Ferinject®)
2011     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation
2011     NIHR Health Technology Assessment programme Golimumab for the treatment of psoriatic arthritis
2011     Andalusian Health Technology Assessment Area (AETSA) [Effectiveness and safety of the HELICA technique in the treatment of endometriosis. Systematic review of the literature]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Dasatinib (Sprycel) for prostate cancer – in combination with docetaxel
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Valganciclovir (Valcyte®) tablets
2011     Andalusian Health Technology Assessment Area (AETSA) [Vaccine against Neisseria meningitidis serogroup B]
2011     NIHR Horizon Scanning Centre (NIHR HSC) EC145 for folate receptor positive ovarian cancer
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Valganciclovir (Valcyte®) powder for oral solution
2011     National Institute for Health and Care Excellence (NICE) moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment. NICE medical technologies guidance 2
2011     NIHR Health Technology Assessment programme Evidence Review Group approaches to the critical appraisal of manufacturer submissions for the NICE STA process: a mapping study and thematic analysis
2011     Andalusian Health Technology Assessment Area (AETSA) [Botulinum toxin A in the treatment of morbid obesity]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) in combination with sorafenib (Nexavar) for unresectable, advanced or metastatic hepatocellular carcinoma – first line
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Capecitabine (Xeloda®)
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [Psychological treatment of personality disorders: a multi-centered randomised controlled trial on the (cost-)effectiveness of schema-focused therapy]
2011     Basque Office for Health Technology Assessment (OSTEBA) [Proposed health survey of the Basque Country for institutionalised population in nursing homes (ESCAV-IR). CAPV 2010]
2011     Andalusian Health Technology Assessment Area (AETSA) [Effectiveness and safety of percutaneous treatment of pelvic ring fractures]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Heat-activated liposome encapsulated doxorubicin (ThermoDox) for hepatocellular carcinoma – first line
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tacrolimus (Advagraf®)
2011     NIHR Health Technology Assessment programme Development and evaluation by a cluster randomised trial of a psychosocial intervention in children and teenagers experiencing diabetes: the DEPICTED study
2011     Norwegian Knowledge Centre for the Health Services (NOKC) [Treatment of chronic fatigue syndrome CFS/ME]
2011     Andalusian Health Technology Assessment Area (AETSA) [Effectiveness and safety of active immunotherapy against telomerase in solid-organ cancer]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Ipilimumab (Yervoy) for prostate cancer – second line
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Fentanyl (PecFent®)
2011     Agency for Healthcare Research and Quality (AHRQ) Adjunctive devices for patients with acute coronary syndrome undergoing percutaneous coronary intervention
2011     Haute Autorite de sante (HAS) [Transcutaneous aortic valve implantation by the transfemoral or transapical route]
2011     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Renal denervation in patients with essential hypertonia]
2011     Andalusian Health Technology Assessment Area (AETSA) [Prioritization of patient decision aids]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib with gemcitabine for advanced or metastatic pancreatic cancer
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Darunavir (Prezista®)
2011     Agency for Healthcare Research and Quality (AHRQ) Effectiveness of early diagnosis, prevention, and treatment of clostridium difficile infection
2011     Scottish Health Technologies Group (SHTG) What is the clinical and cost effectiveness of the ThinPrep imager® (HologicTM, Inc) for assisted cervical cytology compared with manual reading of liquid based cytology slides?
2011     Haute Autorite de sante (HAS) [Assessment of glomerular filtration rate and serum creatinine levels in the diagnosis of chronic kidney disease in adults]
2011     NIHR Health Technology Assessment programme A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-a) inhibitors, adalimumab and infliximab, for Crohn's disease
2011     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of management strategies for sciatica: systematic review and economic model
2011     NIHR Health Technology Assessment programme Evaluating meta-ethnography: systematic analysis and synthesis of qualitative research
2011     Penn Medicine Center for Evidence-based Practice (CEP) Tests for early diagnosis of sepsis
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part I: Epidemiology - incidence of risk factors and diseases in pregnancy and early childhood]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Paclitaxel (Paclical) for epithelial ovarian cancer, fallopian tube cancer or peritoneal cancer – second or third line
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Valsartan (Diovan®)
2011     Agency for Healthcare Research and Quality (AHRQ) Second-generation antidepressants in the pharmacologic treatment of adult depression: an update of the 2007 comparative effectiveness review
2011     Scottish Health Technologies Group (SHTG) The clinical and cost effectiveness of the use of brachytherapy to treat breast cancer
2011     Haute Autorite de sante (HAS) [Albumin (or protein) to creatinine ratios in the diagnosis of chronic kidney disease in adults]
2011     Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for management of sepsis
2011     Belgian Health Care Knowledge Centre (KCE) Transcatheter aortic valve implantation (TAVI): an updated health technology assessment
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part II: international policies, approaches and screening strategies to "normal" and "risk experiences" during pregnancy and early childhood to school entry]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Caris Target Now™ molecular profiling service for solid malignant tumours
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Filgrastim (Nivestim®)
2011     Agency for Healthcare Research and Quality (AHRQ) Analgesics for osteoarthritis: an update of the 2006 comparative effectiveness review
2011     Scottish Health Technologies Group (SHTG) What is the evidence base for the use of orthopaedic spinal surgery for mechanical low back pain or degenerative spondylolisthesis?
2011     Haute Autorite de sante (HAS) [MRI-guided vacuum-assisted breast biopsy (VABB)]
2011     Penn Medicine Center for Evidence-based Practice (CEP) Impact of retracted articles on the evidence base for hydroxyethyl starch
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part III: Status quo of the financing and cost structures of parent-child services in Austria]
2011     Agency for Healthcare Research and Quality (AHRQ) Attention deficit hyperactivity disorder: effectiveness of treatment in at-risk preschoolers; long-term effectiveness in all ages; and variability in prevalence, diagnosis, and treatment
2011     Scottish Health Technologies Group (SHTG) The clinical and cost effectiveness of the use of brachytherapy to treat localised prostate cancer
2011     Penn Medicine Center for Evidence-based Practice (CEP) Tunneled vs. non-tunneled catheters for acute hemodialysis
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Reorientation of the Austrian parent-child preventive care programme. Part IV: synthesis of parts 1-3, recommendations]
2011     Agency for Healthcare Research and Quality (AHRQ) Angiotensin-converting enzyme inhibitors (ACEIs), angiotensin II receptor antagonists (ARBs), and direct renin inhibitors for treating essential hypertension: an update
2011     Scottish Health Technologies Group (SHTG) Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults. This evidence note updates evidence note 33 published in March 2011
2011     Haute Autorite de sante (HAS) [Surgical haemostatic agents: treatments of last resort]
2011     National Institute for Health and Care Excellence (NICE) Ambulight PDT for the treatment of non-melanoma skin cancer. NICE medical technologies guidance 6
2011     NIHR Health Technology Assessment programme Identification of risk factors by systematic review and development of risk-adjusted models for surgical site infection
2011     Penn Medicine Center for Evidence-based Practice (CEP) Active management and treatment of postpartum hemorrhage
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Disinvestment. Overview of disinvestment experiences and challenges in selected countries
2011     NIHR Horizon Scanning Centre (NIHR HSC) Dalcetrapib for the prevention of cardiovascular events
2011     Scottish Health Technologies Group (SHTG) The clinical and cost effectiveness of long-term ventricular assist devices (VADs) as a bridge-to-transplant in adults
2011     Haute Autorite de sante (HAS) [Biology of haemostasis disorders: bleeding time]
2011     National Institute for Health and Care Excellence (NICE) The MIST Therapy system for the promotion of wound healing. NICE medical technologies guidance 5
2011     NIHR Health Technology Assessment programme A randomised controlled trial of post-operative radiotherapy following breast-conserving surgery in a minimum-risk population. Quality of life at 5 years in the PRIME trial
2011     Penn Medicine Center for Evidence-based Practice (CEP) Risk factors for hospital readmission
2011     HAYES, Inc. Acticoat (Smith&Nephew Inc.) for Burn Wounds
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Eribulin (Halaven) as third- or late- line mono-therapy for advanced/metastatic breast cancer
2011     NIHR Horizon Scanning Centre (NIHR HSC) Edoxaban tosylate for prevention of stroke and systemic embolic events in non-valvular atrial fibrillation
2011     Scottish Health Technologies Group (SHTG) Is radiofrequency ablation treatment a clinically and cost effective treatment to be offered to people with renal cancer in NHSScotland?
2011     Haute Autorite de sante (HAS) [Biology of haemostasis disorders: thrombin time]
2011     Penn Medicine Center for Evidence-based Practice (CEP) Femoral closure devices for cardiac catheterization
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Sacral nerve stimulation for fecal incontinence]
2011     NIHR Horizon Scanning Centre (NIHR HSC) HHLivC (Human Heterologous Liver Cells) for urea cycle disorders
2011     Haute Autorite de sante (HAS) [Biology of haemostasis disorders: photometric platelet aggregation test]
2011     Penn Medicine Center for Evidence-based Practice (CEP) Transradial access for cardiac catheterization
2011     HAYES, Inc. Antibacterial suture for prevention of infection
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Percutaneuous left atrial appendage closure for the prevention of thrombo-embolic events in patients with atrial fibrillation]
2011     Haute Autorite de sante (HAS) [Biology of haemostasis disorders: testing for antibodies to platelet factor 4 in a patient with heparin – induced thrombocytopenia]
2011     Penn Medicine Center for Evidence-based Practice (CEP) Guidelines for verifying Dobbhoff tube placement
2011     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) [Mechanical percutaneous transluminal cerebral clot retrieval in acute ischemic stroke]
2011     NIHR Horizon Scanning Centre (NIHR HSC) IRay™ for wet age related macular degeneration